Zoetis Inc.
164.36
-1.96 (-1.18%)
At close: Jan 14, 2025, 3:59 PM
164.41
0.03%
After-hours Jan 14, 2025, 07:00 PM EST
undefined%
Bid 159
Market Cap 74.15B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 5.32
PE Ratio (ttm) 30.89
Forward PE n/a
Analyst Buy
Ask 170.69
Volume 2,663,360
Avg. Volume (20D) 2,484,704
Open 166.42
Previous Close 166.32
Day's Range 161.58 - 166.92
52-Week Range 144.80 - 200.53
Beta undefined

About ZTS

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respirat...

Sector Healthcare
IPO Date Feb 1, 2013
Employees 14,100
Stock Exchange NYSE
Ticker Symbol ZTS

Analyst Forecast

According to 8 analyst ratings, the average rating for ZTS stock is "Buy." The 12-month stock price forecast is $220, which is an increase of 33.85% from the latest price.

Buy 100.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Zoetis Inc. is scheduled to release its earnings on Feb 13, 2025, before market opens.
Analysts project revenue of $2.35B, reflecting a 6.19% YoY growth and earnings per share of 1.43, making a 15.32% increase YoY.
5 months ago · Source
+5.99%
Zoetis shares are trading higher after the company... Unlock content with Pro Subscription
8 months ago · Source
+5.51%
Zoetis shares are trading higher after the company reported better-than-expected Q1 financial results.